Compare CBSH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBSH | HALO |
|---|---|---|
| Founded | 1865 | 1998 |
| Country | United States | United States |
| Employees | 4737 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.8B |
| IPO Year | 2008 | 2001 |
| Metric | CBSH | HALO |
|---|---|---|
| Price | $52.32 | $68.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 11 |
| Target Price | $58.28 | ★ $78.64 |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 4.39 | N/A |
| EPS | 0.96 | ★ 1.22 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | $17.43 | $28.24 |
| Revenue Next Year | $3.43 | $12.56 |
| P/E Ratio | ★ $54.41 | $56.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.99 | $51.06 |
| 52 Week High | $66.31 | $82.22 |
| Indicator | CBSH | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 57.29 | 54.11 |
| Support Level | $50.93 | $67.94 |
| Resistance Level | $54.23 | $69.95 |
| Average True Range (ATR) | 1.08 | 2.70 |
| MACD | 0.03 | 0.20 |
| Stochastic Oscillator | 75.92 | 45.62 |
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.